[ESPR] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 17.39%
YoY- 39.88%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 73,834 137,735 32,250 33,969 25,786 24,329 18,818 148.97%
PBT -61,925 61,022 -56,344 -41,250 -49,935 -61,719 -55,487 7.59%
Tax 0 -41 -27,424 -26 -51 27,501 12,974 -
NP -61,925 61,022 -56,344 -41,250 -49,935 -89,220 -68,461 -6.47%
Tax Rate - 0.07% - - - - - -
Total Cost 135,759 76,713 88,594 75,219 75,721 113,549 87,279 34.28%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -83.87 44.30 -174.71 -121.43 -193.65 -366.72 -363.81 -62.43%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.33 0.36 -0.50 -0.37 -0.46 -1.14 -0.93 -49.91%
EPS Diluted -0.33 0.34 -0.50 -0.37 -0.46 -1.14 -0.93 -49.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.